Table 2 Ontology analysis of the genes that were expressed at significantly different levels between all 35 patients, or the subgroups consisting of 20 IFN^high and 15 IFN^low patients, and healthy controls.

	All patients	IFNhigh	IFNlow
Biological process	p Value	p Value	p Value
Immunity and defence	1.61E−11	3.41E−15	NS
Interferon‐mediated immunity	1.09E−06	3.38E−08	NS
Macrophage‐mediated immunity	6.83E−05	1.27E−04	NS
Lipid and fatty acid transport	1.54E−04	NS	NS
Transport	4.82E−04	3.33E−02	NS
Cytokine/chemokine‐mediated immunity	1.63E−03	2.61E−05	NS
Ligand‐mediated signalling	3.52E−03	1.92E−02	NS
Cell motility	NS	4.24E−03	NS
Blood clotting	NS	5.30E−03	NS
Oncogenesis	NS	1.04E−02	NS
Cell structure and motility	NS	1.55E−02	NS
Inhibition of apoptosis	NS	1.66E−02	NS
Signal transduction	NS	3.21E−02	NS
Proteolysis	NS	3.97E−02	NS

NS, nonsignificant.

Processes with a p value <0.05 were considered significant (with Bonferroni correction).